| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 118 | 2024 | 4027 | 11.640 |
Why?
|
| Fatty Acids, Nonesterified | 22 | 2023 | 393 | 6.240 |
Why?
|
| Hip Fractures | 20 | 2024 | 988 | 4.990 |
Why?
|
| Hypotension, Orthostatic | 11 | 2023 | 258 | 4.380 |
Why?
|
| Coronary Disease | 49 | 2023 | 5919 | 4.050 |
Why?
|
| Hypertension | 50 | 2024 | 8539 | 3.690 |
Why?
|
| Cardiovascular Diseases | 89 | 2024 | 15499 | 3.620 |
Why?
|
| Aged | 363 | 2024 | 169179 | 2.800 |
Why?
|
| Osteoporotic Fractures | 8 | 2024 | 411 | 2.730 |
Why?
|
| Peripheral Arterial Disease | 16 | 2023 | 1272 | 2.710 |
Why?
|
| Insulin Resistance | 27 | 2023 | 3956 | 2.640 |
Why?
|
| Myocardial Infarction | 64 | 2024 | 11454 | 2.590 |
Why?
|
| Procollagen | 8 | 2015 | 187 | 2.560 |
Why?
|
| Risk Factors | 256 | 2024 | 74152 | 2.560 |
Why?
|
| Antihypertensive Agents | 16 | 2024 | 2023 | 2.450 |
Why?
|
| Behavioral Risk Factor Surveillance System | 10 | 2024 | 208 | 2.140 |
Why?
|
| Diabetes Mellitus | 32 | 2022 | 5841 | 2.130 |
Why?
|
| Male | 423 | 2024 | 360621 | 2.120 |
Why?
|
| Prospective Studies | 170 | 2024 | 54405 | 2.050 |
Why?
|
| Peptide Fragments | 16 | 2023 | 5114 | 2.010 |
Why?
|
| Blood Glucose | 34 | 2023 | 6389 | 1.970 |
Why?
|
| Female | 423 | 2024 | 392485 | 1.950 |
Why?
|
| Humans | 558 | 2024 | 761326 | 1.880 |
Why?
|
| Dihydrotestosterone | 4 | 2022 | 195 | 1.850 |
Why?
|
| Incidence | 95 | 2024 | 21336 | 1.850 |
Why?
|
| Atrial Fibrillation | 24 | 2024 | 5127 | 1.850 |
Why?
|
| Dementia | 15 | 2024 | 2686 | 1.800 |
Why?
|
| United States | 162 | 2024 | 72317 | 1.770 |
Why?
|
| Blood Pressure | 37 | 2024 | 8485 | 1.710 |
Why?
|
| Proportional Hazards Models | 81 | 2024 | 12450 | 1.710 |
Why?
|
| Ethanol | 11 | 2019 | 1324 | 1.700 |
Why?
|
| Middle Aged | 270 | 2024 | 220774 | 1.640 |
Why?
|
| Aged, 80 and over | 130 | 2024 | 58946 | 1.620 |
Why?
|
| Heart Failure | 36 | 2023 | 11672 | 1.610 |
Why?
|
| Cardiovascular System | 7 | 2024 | 835 | 1.590 |
Why?
|
| Fatty Acid-Binding Proteins | 5 | 2020 | 296 | 1.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 40 | 2023 | 12144 | 1.520 |
Why?
|
| Influenza Vaccines | 4 | 2022 | 767 | 1.470 |
Why?
|
| Risk Assessment | 60 | 2024 | 23981 | 1.440 |
Why?
|
| Brachial Artery | 4 | 2021 | 366 | 1.430 |
Why?
|
| Atherosclerosis | 18 | 2023 | 3413 | 1.420 |
Why?
|
| Bone Density | 12 | 2024 | 3551 | 1.410 |
Why?
|
| Mobility Limitation | 4 | 2023 | 408 | 1.410 |
Why?
|
| Blood Pressure Determination | 9 | 2024 | 634 | 1.370 |
Why?
|
| Lysine | 5 | 2019 | 991 | 1.360 |
Why?
|
| Fasting | 14 | 2022 | 1602 | 1.350 |
Why?
|
| Alcoholic Beverages | 12 | 2023 | 264 | 1.340 |
Why?
|
| Apolipoproteins | 4 | 2022 | 326 | 1.320 |
Why?
|
| Kidney Failure, Chronic | 10 | 2022 | 2471 | 1.320 |
Why?
|
| Catechol O-Methyltransferase | 4 | 2019 | 251 | 1.310 |
Why?
|
| C-Reactive Protein | 18 | 2023 | 3824 | 1.300 |
Why?
|
| Natriuretic Peptide, Brain | 10 | 2023 | 1723 | 1.290 |
Why?
|
| Health Surveys | 22 | 2021 | 4059 | 1.280 |
Why?
|
| Cross-Sectional Studies | 66 | 2024 | 26108 | 1.270 |
Why?
|
| Hospitalization | 19 | 2021 | 10715 | 1.270 |
Why?
|
| Transforming Growth Factor beta | 6 | 2017 | 1959 | 1.260 |
Why?
|
| Nutrition Surveys | 15 | 2024 | 1728 | 1.260 |
Why?
|
| Coffee | 6 | 2020 | 593 | 1.260 |
Why?
|
| Longitudinal Studies | 54 | 2024 | 14597 | 1.230 |
Why?
|
| Disabled Persons | 4 | 2023 | 1225 | 1.220 |
Why?
|
| Follow-Up Studies | 85 | 2024 | 39108 | 1.220 |
Why?
|
| Albuminuria | 8 | 2024 | 657 | 1.180 |
Why?
|
| Diet, Sodium-Restricted | 4 | 2023 | 292 | 1.170 |
Why?
|
| Beer | 6 | 2024 | 134 | 1.140 |
Why?
|
| Life Style | 24 | 2019 | 3915 | 1.130 |
Why?
|
| Stroke | 31 | 2024 | 9749 | 1.120 |
Why?
|
| Adult | 181 | 2024 | 221122 | 1.100 |
Why?
|
| Suicide | 11 | 2016 | 1598 | 1.090 |
Why?
|
| Hemoglobins | 4 | 2024 | 1524 | 1.090 |
Why?
|
| Exercise | 13 | 2024 | 5883 | 1.080 |
Why?
|
| Adiponectin | 10 | 2023 | 1113 | 1.070 |
Why?
|
| Academic Medical Centers | 8 | 2019 | 2760 | 1.070 |
Why?
|
| Body Mass Index | 38 | 2024 | 12949 | 1.060 |
Why?
|
| Independent Living | 9 | 2022 | 579 | 1.040 |
Why?
|
| Activities of Daily Living | 7 | 2023 | 2421 | 1.040 |
Why?
|
| Ankle Brachial Index | 11 | 2023 | 163 | 1.020 |
Why?
|
| Heart Rate | 6 | 2022 | 4197 | 1.010 |
Why?
|
| Body Height | 6 | 2016 | 1570 | 1.010 |
Why?
|
| Creatinine | 8 | 2021 | 1899 | 1.010 |
Why?
|
| Glomerular Filtration Rate | 12 | 2021 | 2176 | 0.980 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 4 | 2016 | 127 | 0.980 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2020 | 1005 | 0.960 |
Why?
|
| Cohort Studies | 68 | 2024 | 41440 | 0.960 |
Why?
|
| Lipoproteins, HDL | 9 | 2023 | 675 | 0.960 |
Why?
|
| Prevalence | 43 | 2021 | 15719 | 0.940 |
Why?
|
| American Cancer Society | 1 | 2024 | 69 | 0.930 |
Why?
|
| Health Behavior | 11 | 2022 | 2641 | 0.930 |
Why?
|
| Coronary Artery Disease | 19 | 2022 | 6392 | 0.930 |
Why?
|
| Renal Insufficiency, Chronic | 11 | 2024 | 2241 | 0.920 |
Why?
|
| Protein Precursors | 3 | 2020 | 1134 | 0.920 |
Why?
|
| Polymorphism, Single Nucleotide | 30 | 2024 | 15879 | 0.910 |
Why?
|
| Cause of Death | 22 | 2021 | 3685 | 0.880 |
Why?
|
| Norway | 13 | 2024 | 498 | 0.870 |
Why?
|
| Prognosis | 52 | 2024 | 29588 | 0.870 |
Why?
|
| Fibroblast Growth Factors | 8 | 2017 | 867 | 0.860 |
Why?
|
| Insulin | 22 | 2023 | 6595 | 0.850 |
Why?
|
| Health Status Indicators | 3 | 2018 | 968 | 0.840 |
Why?
|
| Magnesium | 7 | 2014 | 809 | 0.840 |
Why?
|
| Fatty Acids | 10 | 2023 | 1806 | 0.840 |
Why?
|
| Dietary Fats | 4 | 2023 | 1994 | 0.830 |
Why?
|
| Multivariate Analysis | 32 | 2024 | 12059 | 0.820 |
Why?
|
| Tea | 5 | 2011 | 287 | 0.820 |
Why?
|
| Continuity of Patient Care | 3 | 2014 | 1069 | 0.810 |
Why?
|
| Influenza, Human | 3 | 2022 | 1521 | 0.800 |
Why?
|
| Hypercholesterolemia | 6 | 2022 | 1142 | 0.800 |
Why?
|
| Lipoproteins | 4 | 2022 | 881 | 0.800 |
Why?
|
| Cystatin C | 6 | 2021 | 270 | 0.800 |
Why?
|
| Resistance Training | 2 | 2014 | 193 | 0.790 |
Why?
|
| Age Factors | 33 | 2024 | 18401 | 0.790 |
Why?
|
| Physical Fitness | 2 | 2018 | 739 | 0.790 |
Why?
|
| Taxes | 1 | 2024 | 221 | 0.780 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2022 | 550 | 0.780 |
Why?
|
| Liver Cirrhosis | 7 | 2021 | 1934 | 0.780 |
Why?
|
| Vascular Diseases | 6 | 2024 | 1161 | 0.780 |
Why?
|
| Cholesterol, HDL | 15 | 2023 | 1814 | 0.780 |
Why?
|
| Time Factors | 50 | 2024 | 39974 | 0.770 |
Why?
|
| Coronary Artery Bypass | 8 | 2009 | 2189 | 0.770 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2021 | 1392 | 0.760 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 395 | 0.760 |
Why?
|
| Apolipoprotein C-III | 5 | 2022 | 209 | 0.750 |
Why?
|
| Obesity | 29 | 2023 | 12934 | 0.740 |
Why?
|
| Lead | 6 | 2024 | 879 | 0.740 |
Why?
|
| Sex Factors | 20 | 2019 | 10551 | 0.730 |
Why?
|
| Metals, Heavy | 1 | 2022 | 147 | 0.730 |
Why?
|
| Clinical Enzyme Tests | 2 | 2019 | 115 | 0.720 |
Why?
|
| Vitamin D Deficiency | 3 | 2014 | 1385 | 0.700 |
Why?
|
| Length of Stay | 5 | 2019 | 6422 | 0.700 |
Why?
|
| Retinal Diseases | 3 | 2024 | 704 | 0.700 |
Why?
|
| Diet | 19 | 2024 | 8074 | 0.690 |
Why?
|
| Guideline Adherence | 4 | 2024 | 2221 | 0.690 |
Why?
|
| Diabetes Complications | 6 | 2015 | 1317 | 0.690 |
Why?
|
| Kidney Diseases | 6 | 2019 | 2093 | 0.680 |
Why?
|
| Periodontitis | 3 | 2017 | 562 | 0.680 |
Why?
|
| Patient Discharge | 8 | 2018 | 3438 | 0.670 |
Why?
|
| Accidental Falls | 5 | 2023 | 1068 | 0.660 |
Why?
|
| Hospitalists | 2 | 2013 | 294 | 0.660 |
Why?
|
| Body Composition | 4 | 2021 | 2422 | 0.660 |
Why?
|
| Apolipoproteins E | 8 | 2022 | 1444 | 0.650 |
Why?
|
| Acute Coronary Syndrome | 2 | 2024 | 2191 | 0.650 |
Why?
|
| Odds Ratio | 21 | 2021 | 9639 | 0.650 |
Why?
|
| Carotid Artery Diseases | 4 | 2018 | 877 | 0.640 |
Why?
|
| Vasodilation | 2 | 2021 | 961 | 0.640 |
Why?
|
| Intermittent Claudication | 2 | 2014 | 304 | 0.640 |
Why?
|
| Parity | 5 | 2024 | 927 | 0.640 |
Why?
|
| Fibrosis | 6 | 2015 | 2048 | 0.640 |
Why?
|
| Lipoproteins, VLDL | 3 | 2018 | 201 | 0.640 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 5439 | 0.630 |
Why?
|
| Lovastatin | 3 | 2008 | 116 | 0.630 |
Why?
|
| Body Size | 1 | 2021 | 463 | 0.620 |
Why?
|
| Testosterone | 3 | 2022 | 2472 | 0.620 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2022 | 2119 | 0.620 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 329 | 0.620 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 181 | 0.620 |
Why?
|
| Aging | 16 | 2023 | 8704 | 0.620 |
Why?
|
| Logistic Models | 26 | 2021 | 13251 | 0.610 |
Why?
|
| Heart Diseases | 5 | 2021 | 2785 | 0.610 |
Why?
|
| Blood Flow Velocity | 2 | 2020 | 1370 | 0.610 |
Why?
|
| Mortality | 8 | 2021 | 2898 | 0.610 |
Why?
|
| Troponin I | 3 | 2023 | 651 | 0.610 |
Why?
|
| Resuscitation Orders | 1 | 2020 | 270 | 0.610 |
Why?
|
| Erythropoietin | 1 | 2022 | 719 | 0.610 |
Why?
|
| Absorptiometry, Photon | 8 | 2021 | 1737 | 0.610 |
Why?
|
| Chronic Disease | 7 | 2023 | 9319 | 0.600 |
Why?
|
| Aspirin | 5 | 2017 | 3134 | 0.600 |
Why?
|
| Feeding Behavior | 14 | 2022 | 3187 | 0.600 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2018 | 52 | 0.600 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 975 | 0.600 |
Why?
|
| Community-Acquired Infections | 3 | 2013 | 468 | 0.590 |
Why?
|
| Legal Guardians | 1 | 2018 | 57 | 0.590 |
Why?
|
| Linear Models | 18 | 2021 | 5871 | 0.590 |
Why?
|
| Ventricular Function, Left | 9 | 2023 | 3878 | 0.590 |
Why?
|
| Fatty Acids, Monounsaturated | 5 | 2023 | 190 | 0.580 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 329 | 0.580 |
Why?
|
| Risk | 26 | 2020 | 9605 | 0.580 |
Why?
|
| Nutrition Policy | 4 | 2024 | 471 | 0.580 |
Why?
|
| Dizziness | 1 | 2020 | 259 | 0.580 |
Why?
|
| Vitamin K | 3 | 2016 | 318 | 0.580 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2016 | 156 | 0.570 |
Why?
|
| Heart Ventricles | 6 | 2018 | 3816 | 0.570 |
Why?
|
| Fibrinogen | 7 | 2024 | 889 | 0.560 |
Why?
|
| Electrocardiography | 10 | 2023 | 6382 | 0.560 |
Why?
|
| Fractures, Bone | 4 | 2023 | 2046 | 0.560 |
Why?
|
| Health Status | 9 | 2014 | 4075 | 0.560 |
Why?
|
| Homocysteine | 3 | 2015 | 638 | 0.560 |
Why?
|
| Healthcare Disparities | 4 | 2020 | 3357 | 0.560 |
Why?
|
| Quality of Life | 8 | 2020 | 13355 | 0.560 |
Why?
|
| Geriatric Assessment | 4 | 2020 | 1409 | 0.550 |
Why?
|
| Exercise Test | 3 | 2021 | 2129 | 0.540 |
Why?
|
| Case-Control Studies | 36 | 2021 | 22124 | 0.540 |
Why?
|
| Renal Dialysis | 5 | 2024 | 1801 | 0.540 |
Why?
|
| Syncope | 1 | 2019 | 427 | 0.540 |
Why?
|
| Smoking | 24 | 2024 | 9051 | 0.540 |
Why?
|
| Phospholipids | 7 | 2021 | 786 | 0.540 |
Why?
|
| Cerebral Infarction | 2 | 2017 | 983 | 0.540 |
Why?
|
| Chest Pain | 2 | 2019 | 1090 | 0.540 |
Why?
|
| Women's Health | 3 | 2024 | 2065 | 0.530 |
Why?
|
| Potassium | 3 | 2016 | 1311 | 0.530 |
Why?
|
| Heroin Dependence | 1 | 2017 | 172 | 0.530 |
Why?
|
| Brain Chemistry | 1 | 2020 | 959 | 0.530 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 3200 | 0.530 |
Why?
|
| Leukoaraiosis | 1 | 2017 | 116 | 0.530 |
Why?
|
| Prostatic Hyperplasia | 1 | 2020 | 521 | 0.530 |
Why?
|
| Ambulatory Care | 3 | 2016 | 2775 | 0.520 |
Why?
|
| Posture | 2 | 2023 | 956 | 0.520 |
Why?
|
| Hospital Charges | 1 | 2018 | 351 | 0.520 |
Why?
|
| Clonidine | 1 | 2016 | 169 | 0.510 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2016 | 91 | 0.510 |
Why?
|
| Marijuana Smoking | 3 | 2024 | 258 | 0.510 |
Why?
|
| Physical Exertion | 2 | 2012 | 667 | 0.500 |
Why?
|
| Genetic Loci | 8 | 2024 | 2628 | 0.500 |
Why?
|
| Amlodipine | 3 | 2020 | 84 | 0.490 |
Why?
|
| Cognition | 7 | 2022 | 6987 | 0.490 |
Why?
|
| Critical Illness | 7 | 2020 | 2722 | 0.490 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2016 | 215 | 0.480 |
Why?
|
| Triglycerides | 6 | 2022 | 2458 | 0.470 |
Why?
|
| Vaccination | 3 | 2022 | 3381 | 0.470 |
Why?
|
| Genotype | 24 | 2019 | 12982 | 0.460 |
Why?
|
| Betaine | 1 | 2014 | 89 | 0.460 |
Why?
|
| Physical Endurance | 1 | 2016 | 366 | 0.450 |
Why?
|
| Hydroxycholecalciferols | 1 | 2013 | 44 | 0.450 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2015 | 224 | 0.440 |
Why?
|
| Ultrasonography | 7 | 2021 | 5970 | 0.440 |
Why?
|
| beta 2-Microglobulin | 1 | 2014 | 329 | 0.440 |
Why?
|
| Glucose | 9 | 2023 | 4345 | 0.430 |
Why?
|
| Docosahexaenoic Acids | 3 | 2017 | 908 | 0.430 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2013 | 10 | 0.430 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 256 | 0.430 |
Why?
|
| Lipids | 12 | 2023 | 3341 | 0.420 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2015 | 1555 | 0.420 |
Why?
|
| Socioeconomic Factors | 13 | 2024 | 7824 | 0.420 |
Why?
|
| Inpatients | 2 | 2018 | 2548 | 0.420 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 1809 | 0.420 |
Why?
|
| Gout | 1 | 2020 | 623 | 0.420 |
Why?
|
| Overweight | 6 | 2023 | 2412 | 0.420 |
Why?
|
| Health Personnel | 6 | 2019 | 3335 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 4355 | 0.410 |
Why?
|
| Triage | 1 | 2019 | 986 | 0.410 |
Why?
|
| Proton Pump Inhibitors | 3 | 2019 | 531 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2024 | 17872 | 0.400 |
Why?
|
| Choline | 1 | 2014 | 514 | 0.400 |
Why?
|
| Genetic Variation | 7 | 2019 | 6571 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 2273 | 0.400 |
Why?
|
| Intermediate Filaments | 2 | 2023 | 172 | 0.390 |
Why?
|
| Microcirculation | 2 | 2016 | 1269 | 0.390 |
Why?
|
| Myocardial Ischemia | 3 | 2016 | 2110 | 0.390 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2014 | 111 | 0.390 |
Why?
|
| Vitamin B Complex | 1 | 2014 | 298 | 0.390 |
Why?
|
| Genome-Wide Association Study | 17 | 2024 | 12666 | 0.390 |
Why?
|
| Brain Ischemia | 9 | 2021 | 3048 | 0.390 |
Why?
|
| Beverages | 4 | 2017 | 821 | 0.390 |
Why?
|
| Medicare | 10 | 2020 | 6758 | 0.390 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 355 | 0.390 |
Why?
|
| Colorectal Neoplasms | 3 | 2024 | 6901 | 0.390 |
Why?
|
| Insurance, Health | 3 | 2019 | 2495 | 0.390 |
Why?
|
| Wine | 5 | 2023 | 166 | 0.390 |
Why?
|
| Medicaid | 2 | 2022 | 2817 | 0.390 |
Why?
|
| Alcohol-Related Disorders | 2 | 2018 | 238 | 0.380 |
Why?
|
| Heterozygote | 2 | 2015 | 2803 | 0.380 |
Why?
|
| Endonucleases | 1 | 2014 | 369 | 0.380 |
Why?
|
| Cardiology | 1 | 2022 | 1667 | 0.380 |
Why?
|
| Trans Fatty Acids | 3 | 2021 | 155 | 0.380 |
Why?
|
| Glucose Tolerance Test | 5 | 2018 | 1178 | 0.370 |
Why?
|
| Critical Care | 2 | 2020 | 2697 | 0.360 |
Why?
|
| Acute Kidney Injury | 4 | 2020 | 1926 | 0.360 |
Why?
|
| Inflammation | 11 | 2023 | 10760 | 0.360 |
Why?
|
| Hemostatics | 3 | 2024 | 241 | 0.360 |
Why?
|
| Sweden | 11 | 2024 | 1379 | 0.360 |
Why?
|
| Depression | 7 | 2022 | 8122 | 0.360 |
Why?
|
| Weight Loss | 5 | 2022 | 2683 | 0.350 |
Why?
|
| Micronutrients | 1 | 2013 | 381 | 0.350 |
Why?
|
| Chlorthalidone | 2 | 2020 | 21 | 0.350 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 860 | 0.350 |
Why?
|
| Survivors | 6 | 2014 | 2370 | 0.350 |
Why?
|
| Pneumonia | 3 | 2013 | 2140 | 0.350 |
Why?
|
| Comorbidity | 16 | 2023 | 10498 | 0.350 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 628 | 0.350 |
Why?
|
| Models, Genetic | 1 | 2020 | 3445 | 0.350 |
Why?
|
| Drinking Behavior | 3 | 2019 | 103 | 0.350 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 808 | 0.340 |
Why?
|
| Patient Readmission | 2 | 2014 | 3267 | 0.340 |
Why?
|
| Predictive Value of Tests | 16 | 2024 | 15262 | 0.340 |
Why?
|
| Cholesterol, Dietary | 1 | 2010 | 224 | 0.340 |
Why?
|
| Atenolol | 2 | 2020 | 99 | 0.340 |
Why?
|
| Calcinosis | 2 | 2016 | 1469 | 0.330 |
Why?
|
| Liver | 5 | 2021 | 7531 | 0.330 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2019 | 1517 | 0.330 |
Why?
|
| Adiposity | 8 | 2017 | 1877 | 0.330 |
Why?
|
| Vasculitis | 1 | 2013 | 522 | 0.330 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 64 | 0.330 |
Why?
|
| Body Weight | 6 | 2019 | 4614 | 0.330 |
Why?
|
| Drug Prescriptions | 4 | 2024 | 1669 | 0.320 |
Why?
|
| Haptoglobins | 3 | 2015 | 167 | 0.320 |
Why?
|
| Eggs | 1 | 2010 | 182 | 0.320 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2008 | 537 | 0.320 |
Why?
|
| Dietary Fiber | 3 | 2022 | 759 | 0.320 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 681 | 0.310 |
Why?
|
| Survival Rate | 15 | 2021 | 12710 | 0.310 |
Why?
|
| Genetic Association Studies | 7 | 2019 | 2724 | 0.310 |
Why?
|
| Appendicitis | 2 | 2012 | 675 | 0.310 |
Why?
|
| Lipoprotein Lipase | 1 | 2009 | 133 | 0.310 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3244 | 0.310 |
Why?
|
| Young Adult | 24 | 2024 | 59196 | 0.310 |
Why?
|
| Primary Health Care | 4 | 2016 | 4685 | 0.300 |
Why?
|
| Internal Medicine | 4 | 2017 | 1051 | 0.300 |
Why?
|
| Leukocyte Count | 3 | 2014 | 1597 | 0.300 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3210 | 0.300 |
Why?
|
| Registries | 10 | 2024 | 8223 | 0.300 |
Why?
|
| Lipoproteins, LDL | 4 | 2022 | 642 | 0.300 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2008 | 488 | 0.290 |
Why?
|
| Drinking | 1 | 2009 | 199 | 0.290 |
Why?
|
| Weather | 1 | 2009 | 231 | 0.290 |
Why?
|
| Alcoholic Intoxication | 2 | 2018 | 174 | 0.290 |
Why?
|
| Acculturation | 1 | 2009 | 178 | 0.290 |
Why?
|
| Serum Amyloid P-Component | 1 | 2007 | 46 | 0.290 |
Why?
|
| Cholesterol, LDL | 6 | 2022 | 2381 | 0.290 |
Why?
|
| Cross-Over Studies | 6 | 2024 | 2075 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2024 | 552 | 0.290 |
Why?
|
| Mental Health | 4 | 2018 | 3248 | 0.280 |
Why?
|
| American Heart Association | 2 | 2022 | 1045 | 0.280 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2160 | 0.280 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 1886 | 0.280 |
Why?
|
| Internship and Residency | 6 | 2018 | 5877 | 0.280 |
Why?
|
| Cost of Illness | 2 | 2017 | 1935 | 0.280 |
Why?
|
| Intensive Care Units | 5 | 2016 | 3744 | 0.280 |
Why?
|
| Retirement | 2 | 2006 | 198 | 0.280 |
Why?
|
| Wit and Humor as Topic | 1 | 2006 | 31 | 0.280 |
Why?
|
| Patient Admission | 4 | 2016 | 1367 | 0.280 |
Why?
|
| Hand Strength | 2 | 2021 | 456 | 0.270 |
Why?
|
| Brain | 7 | 2020 | 27103 | 0.270 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2021 | 392 | 0.270 |
Why?
|
| Gene Frequency | 8 | 2016 | 3639 | 0.270 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 3836 | 0.270 |
Why?
|
| Life Expectancy | 3 | 2023 | 1242 | 0.270 |
Why?
|
| Disease Progression | 13 | 2021 | 13500 | 0.260 |
Why?
|
| Defibrillators, Implantable | 1 | 2016 | 1490 | 0.260 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2006 | 27 | 0.260 |
Why?
|
| Denmark | 3 | 2024 | 770 | 0.260 |
Why?
|
| Platelet Count | 1 | 2008 | 781 | 0.260 |
Why?
|
| Gait | 2 | 2024 | 816 | 0.260 |
Why?
|
| Prothrombin | 2 | 2016 | 191 | 0.260 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2012 | 1039 | 0.260 |
Why?
|
| End Stage Liver Disease | 2 | 2021 | 352 | 0.250 |
Why?
|
| Sodium, Dietary | 4 | 2024 | 425 | 0.250 |
Why?
|
| Seasons | 2 | 2020 | 1519 | 0.250 |
Why?
|
| Communication Barriers | 1 | 2009 | 413 | 0.250 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2018 | 152 | 0.250 |
Why?
|
| Faculty, Medical | 3 | 2016 | 1202 | 0.250 |
Why?
|
| Alanine Transaminase | 3 | 2015 | 605 | 0.250 |
Why?
|
| Sunburn | 1 | 2006 | 156 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2016 | 6473 | 0.250 |
Why?
|
| Bone Remodeling | 2 | 2019 | 581 | 0.240 |
Why?
|
| Medical Order Entry Systems | 1 | 2010 | 521 | 0.240 |
Why?
|
| Flavonols | 2 | 2023 | 85 | 0.240 |
Why?
|
| Walking | 1 | 2012 | 1200 | 0.240 |
Why?
|
| Neurofilament Proteins | 2 | 2024 | 336 | 0.240 |
Why?
|
| Albumins | 2 | 2014 | 575 | 0.240 |
Why?
|
| Adolescent | 21 | 2024 | 88305 | 0.240 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2015 | 850 | 0.240 |
Why?
|
| Codeine | 1 | 2024 | 51 | 0.240 |
Why?
|
| Weight Gain | 5 | 2019 | 2346 | 0.240 |
Why?
|
| Epidemiologic Methods | 4 | 2019 | 1336 | 0.240 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 518 | 0.240 |
Why?
|
| Urinalysis | 3 | 2024 | 368 | 0.240 |
Why?
|
| Sleep | 4 | 2018 | 4765 | 0.230 |
Why?
|
| Veterans | 4 | 2012 | 2647 | 0.230 |
Why?
|
| Diabetic Angiopathies | 4 | 2015 | 804 | 0.230 |
Why?
|
| Kidney | 6 | 2021 | 7049 | 0.230 |
Why?
|
| Educational Status | 5 | 2021 | 2520 | 0.230 |
Why?
|
| Substance-Related Disorders | 4 | 2017 | 4419 | 0.230 |
Why?
|
| Medication Errors | 1 | 2010 | 783 | 0.230 |
Why?
|
| Chi-Square Distribution | 8 | 2017 | 3419 | 0.230 |
Why?
|
| Motor Activity | 4 | 2013 | 2710 | 0.230 |
Why?
|
| Retrospective Studies | 30 | 2021 | 80575 | 0.230 |
Why?
|
| Self Report | 6 | 2024 | 3724 | 0.230 |
Why?
|
| Echocardiography | 5 | 2018 | 4991 | 0.230 |
Why?
|
| Health Status Disparities | 1 | 2015 | 1852 | 0.230 |
Why?
|
| Frail Elderly | 3 | 2021 | 763 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 21009 | 0.220 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 411 | 0.220 |
Why?
|
| Isoleucine | 1 | 2023 | 110 | 0.220 |
Why?
|
| Warfarin | 3 | 2008 | 1483 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2017 | 3243 | 0.220 |
Why?
|
| Informed Consent | 2 | 2018 | 1008 | 0.220 |
Why?
|
| Severity of Illness Index | 11 | 2021 | 15835 | 0.220 |
Why?
|
| Ketone Bodies | 1 | 2023 | 76 | 0.220 |
Why?
|
| Brain Diseases | 2 | 2004 | 1545 | 0.220 |
Why?
|
| Switzerland | 1 | 2024 | 324 | 0.220 |
Why?
|
| Models, Statistical | 3 | 2014 | 5078 | 0.220 |
Why?
|
| Fats, Unsaturated | 1 | 2023 | 21 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2019 | 0.220 |
Why?
|
| Double-Blind Method | 9 | 2021 | 12329 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2020 | 10203 | 0.220 |
Why?
|
| Sorbitol | 1 | 2023 | 57 | 0.220 |
Why?
|
| Self Disclosure | 1 | 2004 | 249 | 0.220 |
Why?
|
| Sex Distribution | 7 | 2018 | 2281 | 0.210 |
Why?
|
| Biometry | 1 | 2006 | 562 | 0.210 |
Why?
|
| Fatty Liver | 2 | 2021 | 788 | 0.210 |
Why?
|
| Aspartate Aminotransferases | 2 | 2015 | 416 | 0.210 |
Why?
|
| Morbidity | 2 | 2020 | 1750 | 0.210 |
Why?
|
| Echocardiography, Doppler | 3 | 2018 | 898 | 0.210 |
Why?
|
| Quercetin | 1 | 2023 | 97 | 0.210 |
Why?
|
| Endothelium, Vascular | 3 | 2024 | 4432 | 0.210 |
Why?
|
| Waist Circumference | 4 | 2021 | 934 | 0.210 |
Why?
|
| Cholesterol | 3 | 2023 | 2902 | 0.200 |
Why?
|
| Hematinics | 2 | 2024 | 282 | 0.200 |
Why?
|
| Sodium | 5 | 2024 | 1588 | 0.200 |
Why?
|
| Dilatation | 2 | 2021 | 307 | 0.200 |
Why?
|
| Platelet Aggregation | 1 | 2005 | 773 | 0.200 |
Why?
|
| Leucine | 1 | 2023 | 548 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2014 | 6341 | 0.200 |
Why?
|
| Anticholesteremic Agents | 2 | 2006 | 967 | 0.200 |
Why?
|
| Lipase | 2 | 2018 | 325 | 0.200 |
Why?
|
| Blood Proteins | 2 | 2024 | 1180 | 0.200 |
Why?
|
| Menstrual Cycle | 2 | 2022 | 539 | 0.200 |
Why?
|
| Platelet Activation | 1 | 2005 | 645 | 0.200 |
Why?
|
| Formularies as Topic | 1 | 2002 | 94 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1964 | 0.200 |
Why?
|
| Valine | 1 | 2023 | 408 | 0.200 |
Why?
|
| New York | 1 | 2024 | 874 | 0.200 |
Why?
|
| Lipoprotein(a) | 3 | 2021 | 480 | 0.200 |
Why?
|
| Edema | 2 | 2016 | 770 | 0.200 |
Why?
|
| Ethics, Clinical | 1 | 2002 | 101 | 0.190 |
Why?
|
| Solvents | 1 | 2003 | 294 | 0.190 |
Why?
|
| Boston | 7 | 2023 | 9333 | 0.190 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2001 | 69 | 0.190 |
Why?
|
| Mass Screening | 1 | 2017 | 5428 | 0.190 |
Why?
|
| Hospitals | 6 | 2020 | 3878 | 0.190 |
Why?
|
| Suicide, Attempted | 1 | 2010 | 1398 | 0.190 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 642 | 0.190 |
Why?
|
| Maternal Age | 1 | 2024 | 809 | 0.190 |
Why?
|
| Clinical Competence | 4 | 2018 | 4793 | 0.190 |
Why?
|
| 4-Butyrolactone | 1 | 2021 | 61 | 0.190 |
Why?
|
| Proteomics | 3 | 2024 | 3843 | 0.190 |
Why?
|
| Kupffer Cells | 1 | 2021 | 143 | 0.190 |
Why?
|
| Up-Regulation | 6 | 2016 | 4120 | 0.190 |
Why?
|
| Eye Diseases | 1 | 2007 | 655 | 0.190 |
Why?
|
| Homozygote | 2 | 2016 | 1796 | 0.190 |
Why?
|
| Electronic Health Records | 4 | 2024 | 4812 | 0.190 |
Why?
|
| Menarche | 1 | 2024 | 532 | 0.190 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.180 |
Why?
|
| Dietary Supplements | 5 | 2019 | 3413 | 0.180 |
Why?
|
| Myocardial Revascularization | 2 | 2016 | 792 | 0.180 |
Why?
|
| Cadmium | 1 | 2022 | 213 | 0.180 |
Why?
|
| Headache | 1 | 2009 | 1256 | 0.180 |
Why?
|
| Autocrine Communication | 1 | 2021 | 169 | 0.180 |
Why?
|
| Lignans | 1 | 2021 | 84 | 0.180 |
Why?
|
| Glucuronates | 1 | 2020 | 40 | 0.180 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 20092 | 0.180 |
Why?
|
| Survival Analysis | 8 | 2016 | 10075 | 0.180 |
Why?
|
| Osmolar Concentration | 1 | 2021 | 661 | 0.180 |
Why?
|
| Forearm | 1 | 2023 | 427 | 0.180 |
Why?
|
| Autonomic Nervous System | 2 | 2022 | 701 | 0.180 |
Why?
|
| Peer Review, Health Care | 2 | 2016 | 73 | 0.180 |
Why?
|
| Methylamines | 1 | 2021 | 136 | 0.180 |
Why?
|
| Digital Rectal Examination | 1 | 2020 | 41 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1055 | 0.180 |
Why?
|
| Lisinopril | 1 | 2020 | 61 | 0.170 |
Why?
|
| Diet Records | 3 | 2016 | 427 | 0.170 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2023 | 540 | 0.170 |
Why?
|
| Confidence Intervals | 5 | 2012 | 2927 | 0.170 |
Why?
|
| Nurses | 4 | 2017 | 2478 | 0.170 |
Why?
|
| Atrophy | 2 | 2004 | 1632 | 0.170 |
Why?
|
| Down-Regulation | 3 | 2018 | 2913 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2021 | 276 | 0.170 |
Why?
|
| Food-Processing Industry | 1 | 2019 | 14 | 0.170 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2021 | 109 | 0.170 |
Why?
|
| Factor VII | 2 | 2015 | 139 | 0.170 |
Why?
|
| Urine | 1 | 2021 | 362 | 0.170 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 703 | 0.170 |
Why?
|
| Palmitic Acid | 3 | 2015 | 149 | 0.170 |
Why?
|
| Pulmonary Embolism | 3 | 2024 | 2566 | 0.170 |
Why?
|
| Medical Audit | 4 | 2002 | 453 | 0.170 |
Why?
|
| Thoracic Vertebrae | 1 | 2024 | 596 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2006 | 2246 | 0.170 |
Why?
|
| Disability Evaluation | 2 | 2018 | 1836 | 0.170 |
Why?
|
| Oleic Acids | 1 | 2019 | 74 | 0.170 |
Why?
|
| Caffeine | 1 | 2004 | 700 | 0.170 |
Why?
|
| Energy Intake | 2 | 2020 | 2134 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1842 | 0.170 |
Why?
|
| Central Venous Pressure | 2 | 2016 | 79 | 0.170 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 251 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2015 | 3796 | 0.160 |
Why?
|
| Language | 1 | 2009 | 1539 | 0.160 |
Why?
|
| Food Industry | 1 | 2019 | 67 | 0.160 |
Why?
|
| Ferritins | 1 | 2022 | 597 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2008 | 2025 | 0.160 |
Why?
|
| Counseling | 1 | 2007 | 1546 | 0.160 |
Why?
|
| alpha-Tocopherol | 1 | 2019 | 126 | 0.160 |
Why?
|
| Probability | 3 | 2016 | 2478 | 0.160 |
Why?
|
| Nonlinear Dynamics | 2 | 2018 | 493 | 0.160 |
Why?
|
| Hemostasis | 1 | 2001 | 467 | 0.160 |
Why?
|
| Interviews as Topic | 4 | 2015 | 2696 | 0.160 |
Why?
|
| Anthocyanins | 2 | 2023 | 80 | 0.160 |
Why?
|
| Haplotypes | 4 | 2016 | 2774 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 282 | 0.160 |
Why?
|
| Coronary Angiography | 6 | 2018 | 4472 | 0.160 |
Why?
|
| Anticoagulants | 4 | 2024 | 4813 | 0.160 |
Why?
|
| Hyperglycemia | 4 | 2016 | 1375 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 3 | 2015 | 900 | 0.150 |
Why?
|
| Mitral Valve | 2 | 2017 | 1471 | 0.150 |
Why?
|
| Caloric Restriction | 1 | 2021 | 299 | 0.150 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2019 | 93 | 0.150 |
Why?
|
| Insurance Coverage | 2 | 2022 | 1938 | 0.150 |
Why?
|
| Diuresis | 1 | 2018 | 106 | 0.150 |
Why?
|
| Tauopathies | 1 | 2022 | 320 | 0.150 |
Why?
|
| Metoprolol | 1 | 2018 | 90 | 0.150 |
Why?
|
| Premature Birth | 3 | 2021 | 1782 | 0.150 |
Why?
|
| Prescription Drugs | 2 | 2024 | 631 | 0.150 |
Why?
|
| Cognition Disorders | 4 | 2014 | 3979 | 0.150 |
Why?
|
| Ramipril | 1 | 2018 | 102 | 0.150 |
Why?
|
| Iatrogenic Disease | 5 | 2002 | 539 | 0.150 |
Why?
|
| Motivation | 1 | 2008 | 2006 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 3 | 2019 | 1703 | 0.150 |
Why?
|
| Stroke Volume | 5 | 2023 | 5497 | 0.150 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 1495 | 0.150 |
Why?
|
| Dietary Carbohydrates | 1 | 2023 | 891 | 0.150 |
Why?
|
| Income | 1 | 2006 | 1876 | 0.150 |
Why?
|
| Stearic Acids | 2 | 2014 | 56 | 0.150 |
Why?
|
| Menopause | 2 | 2024 | 1646 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2017 | 318 | 0.150 |
Why?
|
| Apolipoprotein A-I | 1 | 2019 | 299 | 0.150 |
Why?
|
| Asymptomatic Diseases | 2 | 2018 | 587 | 0.150 |
Why?
|
| Flavonoids | 2 | 2023 | 445 | 0.150 |
Why?
|
| Physicians, Primary Care | 1 | 2024 | 623 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 468 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2022 | 3597 | 0.140 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 249 | 0.140 |
Why?
|
| Neoplasms | 7 | 2024 | 22158 | 0.140 |
Why?
|
| Nutritional Status | 2 | 2021 | 1613 | 0.140 |
Why?
|
| Potassium, Dietary | 2 | 2014 | 103 | 0.140 |
Why?
|
| Marfan Syndrome | 1 | 2019 | 236 | 0.140 |
Why?
|
| Matched-Pair Analysis | 2 | 2009 | 283 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2013 | 3429 | 0.140 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1998 | 130 | 0.140 |
Why?
|
| Rheumatic Diseases | 1 | 2024 | 648 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 10764 | 0.140 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2024 | 244 | 0.140 |
Why?
|
| Folic Acid | 2 | 2014 | 1320 | 0.140 |
Why?
|
| Extremities | 1 | 2002 | 867 | 0.140 |
Why?
|
| Apolipoproteins B | 2 | 2021 | 386 | 0.140 |
Why?
|
| Linoleic Acid | 2 | 2021 | 158 | 0.140 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 23 | 0.140 |
Why?
|
| Firearms | 3 | 2009 | 625 | 0.140 |
Why?
|
| Feasibility Studies | 4 | 2021 | 5247 | 0.140 |
Why?
|
| Risk-Taking | 1 | 2022 | 1037 | 0.140 |
Why?
|
| Water-Electrolyte Balance | 2 | 2015 | 325 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2022 | 549 | 0.130 |
Why?
|
| Professional Review Organizations | 5 | 2002 | 48 | 0.130 |
Why?
|
| Placebos | 2 | 2014 | 1667 | 0.130 |
Why?
|
| Vitamin K Deficiency | 1 | 2016 | 24 | 0.130 |
Why?
|
| Medical Records | 4 | 2004 | 1408 | 0.130 |
Why?
|
| Phenotype | 8 | 2024 | 16603 | 0.130 |
Why?
|
| Hospital Mortality | 4 | 2020 | 5291 | 0.130 |
Why?
|
| Pulsatile Flow | 1 | 2017 | 321 | 0.130 |
Why?
|
| Dental Plaque | 1 | 2017 | 209 | 0.130 |
Why?
|
| Drug Utilization | 1 | 2002 | 1188 | 0.130 |
Why?
|
| Interprofessional Relations | 1 | 2002 | 991 | 0.130 |
Why?
|
| Hepatitis, Chronic | 1 | 2016 | 52 | 0.130 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2019 | 396 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 416 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2020 | 64645 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 2208 | 0.130 |
Why?
|
| Osteoporosis | 2 | 2024 | 1605 | 0.130 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 208 | 0.130 |
Why?
|
| Systole | 2 | 2017 | 937 | 0.130 |
Why?
|
| Tooth Loss | 1 | 2017 | 199 | 0.130 |
Why?
|
| Naloxone | 1 | 2018 | 370 | 0.130 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2373 | 0.130 |
Why?
|
| Social Support | 2 | 2023 | 2172 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 575 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 1086 | 0.120 |
Why?
|
| Sigmoidoscopy | 1 | 2015 | 151 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 96 | 0.120 |
Why?
|
| Massachusetts | 5 | 2016 | 8837 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2016 | 299 | 0.120 |
Why?
|
| Ammonia | 1 | 2016 | 237 | 0.120 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2016 | 350 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2017 | 290 | 0.120 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.120 |
Why?
|
| Air Pollution | 1 | 2009 | 2346 | 0.120 |
Why?
|
| Fruit | 2 | 2023 | 1160 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1504 | 0.120 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 708 | 0.120 |
Why?
|
| Uric Acid | 1 | 2021 | 808 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Vegetables | 2 | 2022 | 1196 | 0.120 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 2004 | 0.120 |
Why?
|
| Erythrocytes | 2 | 2014 | 2418 | 0.120 |
Why?
|
| Age of Onset | 5 | 2013 | 3303 | 0.120 |
Why?
|
| Leisure Activities | 1 | 2016 | 308 | 0.120 |
Why?
|
| Poverty | 2 | 2022 | 2697 | 0.120 |
Why?
|
| Creatine Kinase | 3 | 2003 | 686 | 0.120 |
Why?
|
| Dental Plaque Index | 1 | 2014 | 95 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1650 | 0.120 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2014 | 94 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2020 | 7045 | 0.120 |
Why?
|
| Periodontal Index | 1 | 2014 | 151 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1186 | 0.120 |
Why?
|
| Femur | 1 | 2020 | 1308 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 909 | 0.110 |
Why?
|
| Medically Uninsured | 1 | 2019 | 835 | 0.110 |
Why?
|
| Periodontal Pocket | 1 | 2014 | 170 | 0.110 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2015 | 109 | 0.110 |
Why?
|
| Liver Function Tests | 1 | 2015 | 522 | 0.110 |
Why?
|
| Ticlopidine | 1 | 1998 | 730 | 0.110 |
Why?
|
| Proteome | 1 | 2024 | 1863 | 0.110 |
Why?
|
| Drug Substitution | 1 | 2016 | 289 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2022 | 1127 | 0.110 |
Why?
|
| Riboflavin | 1 | 2014 | 106 | 0.110 |
Why?
|
| Self-Assessment | 1 | 2016 | 396 | 0.110 |
Why?
|
| Hip Joint | 1 | 2020 | 1013 | 0.110 |
Why?
|
| Snoring | 1 | 2015 | 209 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 934 | 0.110 |
Why?
|
| Psychotherapy | 1 | 2022 | 1647 | 0.110 |
Why?
|
| alpha-Linolenic Acid | 2 | 2011 | 144 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3806 | 0.110 |
Why?
|
| Vitamin D | 3 | 2023 | 3304 | 0.110 |
Why?
|
| Terrorism | 1 | 2016 | 211 | 0.110 |
Why?
|
| Diuretics | 2 | 2015 | 610 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2021 | 36430 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 897 | 0.110 |
Why?
|
| Diabetic Retinopathy | 2 | 2013 | 1274 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1168 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2017 | 941 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 352 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 873 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2014 | 214 | 0.110 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8592 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 499 | 0.100 |
Why?
|
| Primary Prevention | 2 | 2023 | 1186 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 1230 | 0.100 |
Why?
|
| Minority Groups | 1 | 2020 | 1203 | 0.100 |
Why?
|
| Diet Surveys | 3 | 2012 | 1162 | 0.100 |
Why?
|
| Thyroid Nodule | 1 | 2020 | 764 | 0.100 |
Why?
|
| Telomere | 1 | 2019 | 941 | 0.100 |
Why?
|
| Apolipoprotein B-100 | 1 | 2013 | 157 | 0.100 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2022 | 1186 | 0.100 |
Why?
|
| Glucuronidase | 1 | 2014 | 202 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 400 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 1176 | 0.100 |
Why?
|
| Pericardium | 1 | 2017 | 675 | 0.100 |
Why?
|
| Meat | 1 | 2015 | 584 | 0.100 |
Why?
|
| Analgesics, Opioid | 3 | 2024 | 3801 | 0.100 |
Why?
|
| Health | 1 | 2015 | 398 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 866 | 0.100 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 675 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2573 | 0.100 |
Why?
|
| Lectins | 1 | 2014 | 491 | 0.100 |
Why?
|
| Calcium Channel Blockers | 2 | 2019 | 694 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 555 | 0.100 |
Why?
|
| Vitamin B 6 | 1 | 2013 | 234 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2001 | 1230 | 0.100 |
Why?
|
| Forecasting | 1 | 2021 | 2928 | 0.100 |
Why?
|
| Long QT Syndrome | 1 | 2016 | 467 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 263 | 0.100 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2014 | 262 | 0.100 |
Why?
|
| Tonsillitis | 1 | 2011 | 28 | 0.100 |
Why?
|
| Histamine H2 Antagonists | 1 | 2013 | 166 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1069 | 0.100 |
Why?
|
| Brain Infarction | 2 | 2021 | 290 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 195 | 0.090 |
Why?
|
| Sarcopenia | 1 | 2016 | 372 | 0.090 |
Why?
|
| Photoperiod | 1 | 2012 | 139 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 836 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 952 | 0.090 |
Why?
|
| Population Groups | 1 | 2012 | 208 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2014 | 991 | 0.090 |
Why?
|
| Leukocytes | 1 | 2019 | 2029 | 0.090 |
Why?
|
| Fibronectins | 1 | 2014 | 723 | 0.090 |
Why?
|
| Research Design | 1 | 2006 | 6178 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2014 | 277 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2020 | 2469 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7852 | 0.090 |
Why?
|
| Pilot Projects | 5 | 2021 | 8632 | 0.090 |
Why?
|
| Migraine Disorders | 2 | 2016 | 1700 | 0.090 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2011 | 303 | 0.090 |
Why?
|
| Pregnancy | 8 | 2024 | 29858 | 0.090 |
Why?
|
| Expert Testimony | 1 | 2013 | 363 | 0.090 |
Why?
|
| Vitamin A | 1 | 2013 | 613 | 0.090 |
Why?
|
| Polypharmacy | 1 | 2013 | 305 | 0.090 |
Why?
|
| Tachycardia, Ventricular | 3 | 2006 | 1304 | 0.090 |
Why?
|
| Postoperative Period | 3 | 2014 | 1813 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 14665 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2187 | 0.090 |
Why?
|
| Aftercare | 1 | 2016 | 913 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6309 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 655 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1931 | 0.090 |
Why?
|
| Fats | 1 | 2010 | 99 | 0.090 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 78 | 0.080 |
Why?
|
| Alleles | 6 | 2019 | 6909 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2019 | 1241 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 1032 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 1088 | 0.080 |
Why?
|
| Coronary Vessels | 3 | 2016 | 3094 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 4927 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1301 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 2691 | 0.080 |
Why?
|
| Air Pressure | 1 | 2009 | 74 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2016 | 2426 | 0.080 |
Why?
|
| Drug Users | 1 | 2011 | 134 | 0.080 |
Why?
|
| Phosphates | 1 | 2013 | 770 | 0.080 |
Why?
|
| Diastole | 1 | 2011 | 782 | 0.080 |
Why?
|
| Longevity | 3 | 2022 | 1065 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2013 | 463 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 1600 | 0.080 |
Why?
|
| Vitamin E | 1 | 2013 | 871 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4576 | 0.080 |
Why?
|
| Sulfur Dioxide | 1 | 2009 | 178 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2009 | 94 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1349 | 0.080 |
Why?
|
| Social Class | 3 | 2016 | 2005 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2007 | 4286 | 0.080 |
Why?
|
| Cacao | 1 | 2009 | 98 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2042 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 997 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3108 | 0.080 |
Why?
|
| Osteocalcin | 2 | 2019 | 274 | 0.080 |
Why?
|
| Age Distribution | 4 | 2016 | 2880 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1474 | 0.080 |
Why?
|
| Humidity | 1 | 2009 | 205 | 0.070 |
Why?
|
| Tonsillectomy | 1 | 2011 | 277 | 0.070 |
Why?
|
| Health Policy | 1 | 2020 | 2684 | 0.070 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 164 | 0.070 |
Why?
|
| Poisoning | 1 | 2009 | 252 | 0.070 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 1066 | 0.070 |
Why?
|
| Software | 2 | 2021 | 4439 | 0.070 |
Why?
|
| Appendectomy | 1 | 2011 | 433 | 0.070 |
Why?
|
| Homeostasis | 2 | 2023 | 3322 | 0.070 |
Why?
|
| Curriculum | 2 | 2018 | 3741 | 0.070 |
Why?
|
| Arteries | 1 | 2012 | 1125 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2015 | 1394 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3310 | 0.070 |
Why?
|
| Netherlands | 3 | 2020 | 2220 | 0.070 |
Why?
|
| Risk Reduction Behavior | 2 | 2013 | 1112 | 0.070 |
Why?
|
| Marital Status | 1 | 2008 | 426 | 0.070 |
Why?
|
| Fishes | 1 | 2010 | 603 | 0.070 |
Why?
|
| Cholesterol, VLDL | 1 | 2007 | 70 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3460 | 0.070 |
Why?
|
| Mental Recall | 1 | 2013 | 1214 | 0.070 |
Why?
|
| Residence Characteristics | 4 | 2012 | 2092 | 0.070 |
Why?
|
| Hippocampus | 1 | 2020 | 3763 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2229 | 0.070 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2010 | 561 | 0.070 |
Why?
|
| Alcoholism | 3 | 2014 | 1973 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1998 | 2751 | 0.070 |
Why?
|
| Demography | 2 | 2001 | 1648 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2332 | 0.070 |
Why?
|
| Spinal Fractures | 1 | 2013 | 705 | 0.070 |
Why?
|
| Air Pollutants, Occupational | 1 | 2009 | 407 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20555 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2016 | 1961 | 0.070 |
Why?
|
| Holidays | 1 | 2006 | 40 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3041 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 809 | 0.070 |
Why?
|
| Databases, Factual | 5 | 2021 | 7954 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2013 | 2603 | 0.070 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1081 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 3 | 2000 | 1792 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 539 | 0.060 |
Why?
|
| Hip | 1 | 2007 | 255 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2018 | 3057 | 0.060 |
Why?
|
| Collagen Type I | 2 | 2019 | 616 | 0.060 |
Why?
|
| Carbon | 1 | 2009 | 665 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 3889 | 0.060 |
Why?
|
| Femur Neck | 1 | 2007 | 314 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2005 | 120 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1871 | 0.060 |
Why?
|
| Models, Biological | 2 | 2015 | 9468 | 0.060 |
Why?
|
| Data Collection | 1 | 2014 | 3324 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 2009 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2013 | 1201 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 3687 | 0.060 |
Why?
|
| Mammography | 1 | 2015 | 2429 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2014 | 3687 | 0.060 |
Why?
|
| Lipid Metabolism | 3 | 2023 | 1900 | 0.060 |
Why?
|
| Sphygmomanometers | 1 | 2024 | 19 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 422 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2006 | 382 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2333 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2013 | 1296 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2011 | 1127 | 0.060 |
Why?
|
| Animals | 9 | 2020 | 168388 | 0.060 |
Why?
|
| Ventricular Fibrillation | 1 | 2006 | 537 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2690 | 0.060 |
Why?
|
| Circadian Rhythm | 3 | 2014 | 2574 | 0.060 |
Why?
|
| Antithrombin III | 1 | 2024 | 128 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 563 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 991 | 0.060 |
Why?
|
| Clinical Clerkship | 2 | 2017 | 564 | 0.060 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2008 | 452 | 0.060 |
Why?
|
| Postoperative Complications | 5 | 2017 | 15647 | 0.050 |
Why?
|
| Connecticut | 5 | 2002 | 364 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2005 | 219 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 2006 | 518 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6478 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2024 | 103 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2018 | 3768 | 0.050 |
Why?
|
| P-Selectin | 1 | 2005 | 597 | 0.050 |
Why?
|
| Carbonated Beverages | 1 | 2004 | 209 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 1277 | 0.050 |
Why?
|
| Students, Medical | 1 | 2016 | 1930 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
| Nursing Audit | 1 | 2002 | 13 | 0.050 |
Why?
|
| Ventricular Remodeling | 2 | 2023 | 1265 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2016 | 14409 | 0.050 |
Why?
|
| Urban Population | 1 | 2010 | 2033 | 0.050 |
Why?
|
| Physicians | 3 | 2017 | 4591 | 0.050 |
Why?
|
| Temperature | 1 | 2009 | 2229 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 1186 | 0.050 |
Why?
|
| Epinephrine | 1 | 2005 | 792 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 957 | 0.050 |
Why?
|
| Follicular Phase | 1 | 2002 | 143 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2021 | 64 | 0.050 |
Why?
|
| Genomics | 2 | 2014 | 5817 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 7390 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 3204 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2004 | 365 | 0.050 |
Why?
|
| Lymphocyte Subsets | 1 | 2022 | 311 | 0.050 |
Why?
|
| Automobile Driving | 1 | 2007 | 441 | 0.050 |
Why?
|
| Oxygen | 1 | 2013 | 4227 | 0.050 |
Why?
|
| Thrombin | 1 | 2024 | 590 | 0.050 |
Why?
|
| Pharmacists | 1 | 2024 | 260 | 0.050 |
Why?
|
| Limbic System | 1 | 2004 | 419 | 0.050 |
Why?
|
| Acute Disease | 4 | 2011 | 7238 | 0.050 |
Why?
|
| Blood Viscosity | 1 | 2001 | 124 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 1444 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2006 | 1415 | 0.050 |
Why?
|
| Antithrombins | 1 | 2024 | 294 | 0.050 |
Why?
|
| Family Health | 1 | 2006 | 1257 | 0.050 |
Why?
|
| Nova Scotia | 1 | 2020 | 34 | 0.050 |
Why?
|
| United States Environmental Protection Agency | 1 | 2021 | 139 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2853 | 0.050 |
Why?
|
| Algorithms | 5 | 2024 | 14025 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2016 | 2637 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3223 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2015 | 322 | 0.050 |
Why?
|
| Sentinel Surveillance | 2 | 2002 | 292 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6231 | 0.050 |
Why?
|
| Carotid Artery, Common | 1 | 2021 | 175 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2021 | 255 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2001 | 277 | 0.040 |
Why?
|
| Anxiety | 2 | 2019 | 4571 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2012 | 2188 | 0.040 |
Why?
|
| Finland | 1 | 2001 | 608 | 0.040 |
Why?
|
| Water Pollutants, Chemical | 1 | 2024 | 356 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8635 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2001 | 332 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7389 | 0.040 |
Why?
|
| Water Supply | 1 | 2021 | 206 | 0.040 |
Why?
|
| Reference Values | 1 | 2007 | 4921 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7872 | 0.040 |
Why?
|
| Physical Examination | 1 | 2006 | 1254 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 285 | 0.040 |
Why?
|
| Depressive Disorder | 3 | 2014 | 3728 | 0.040 |
Why?
|
| California | 5 | 2002 | 1426 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 26 | 0.040 |
Why?
|
| Mass Vaccination | 1 | 2021 | 109 | 0.040 |
Why?
|
| Employment | 1 | 2006 | 1118 | 0.040 |
Why?
|
| Cardiovascular Agents | 2 | 2021 | 840 | 0.040 |
Why?
|
| Reproduction | 1 | 2024 | 645 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8527 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 13333 | 0.040 |
Why?
|
| Live Birth | 1 | 2023 | 511 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2019 | 74 | 0.040 |
Why?
|
| Temperance | 2 | 2010 | 87 | 0.040 |
Why?
|
| Family Relations | 1 | 2001 | 317 | 0.040 |
Why?
|
| Temperament | 1 | 2001 | 297 | 0.040 |
Why?
|
| Kidney Function Tests | 2 | 2012 | 678 | 0.040 |
Why?
|
| Prescriptions | 1 | 2021 | 386 | 0.040 |
Why?
|
| Niacinamide | 1 | 2020 | 413 | 0.040 |
Why?
|
| Nitroglycerin | 1 | 2019 | 329 | 0.040 |
Why?
|
| beta Carotene | 1 | 2019 | 523 | 0.040 |
Why?
|
| Troponin T | 1 | 2023 | 779 | 0.040 |
Why?
|
| Database Management Systems | 1 | 1999 | 257 | 0.040 |
Why?
|
| Infertility | 1 | 2024 | 654 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2001 | 673 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2018 | 504 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 2021 | 682 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2016 | 6937 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1922 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2014 | 2612 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2004 | 1420 | 0.040 |
Why?
|
| Skull | 1 | 2021 | 818 | 0.040 |
Why?
|
| Office Visits | 1 | 2021 | 595 | 0.040 |
Why?
|
| Collagen | 1 | 2005 | 2638 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2009 | 2587 | 0.040 |
Why?
|
| Drugs, Generic | 1 | 2002 | 448 | 0.040 |
Why?
|
| Hepatic Encephalopathy | 1 | 2018 | 144 | 0.030 |
Why?
|
| Mentors | 1 | 2002 | 660 | 0.030 |
Why?
|
| Italy | 1 | 2018 | 841 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1876 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 477 | 0.030 |
Why?
|
| Cerebellum | 1 | 2004 | 1500 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 431 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2016 | 38 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 728 | 0.030 |
Why?
|
| Ascites | 1 | 2018 | 338 | 0.030 |
Why?
|
| Flavones | 1 | 2016 | 68 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5778 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 371 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 1379 | 0.030 |
Why?
|
| Flavanones | 1 | 2016 | 74 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 176 | 0.030 |
Why?
|
| Ohio | 1 | 2016 | 322 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1091 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 6019 | 0.030 |
Why?
|
| Electronic Mail | 1 | 2017 | 213 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2001 | 1164 | 0.030 |
Why?
|
| Eicosanoic Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
| Mice | 3 | 2016 | 81474 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 1791 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 1937 | 0.030 |
Why?
|
| Rabbits | 1 | 2001 | 4779 | 0.030 |
Why?
|
| Androgens | 1 | 2022 | 1286 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 69 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 1118 | 0.030 |
Why?
|
| Child | 4 | 2016 | 80156 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2015 | 236 | 0.030 |
Why?
|
| New England | 1 | 2017 | 1053 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2018 | 723 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2002 | 942 | 0.030 |
Why?
|
| Epilepsy | 1 | 2009 | 3290 | 0.030 |
Why?
|
| Quality of Health Care | 2 | 2016 | 4330 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 3249 | 0.030 |
Why?
|
| Resistin | 1 | 2014 | 172 | 0.030 |
Why?
|
| Television | 1 | 2016 | 408 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 2897 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2002 | 2062 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 470 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 409 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 585 | 0.030 |
Why?
|
| Fragaria | 1 | 2013 | 21 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 943 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2006 | 2365 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 674 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 468 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2018 | 961 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3122 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 139 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2015 | 518 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2012 | 110 | 0.020 |
Why?
|
| Polysomnography | 1 | 2018 | 1847 | 0.020 |
Why?
|
| Thrombosis | 1 | 2005 | 2942 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1156 | 0.020 |
Why?
|
| Patient Care | 1 | 2017 | 621 | 0.020 |
Why?
|
| Specialization | 1 | 2016 | 779 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 120 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2018 | 1337 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 244 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2016 | 1010 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 602 | 0.020 |
Why?
|
| Afghan Campaign 2001- | 1 | 2012 | 298 | 0.020 |
Why?
|
| Immunoassay | 1 | 2014 | 746 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 370 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2017 | 1254 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 245 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 494 | 0.020 |
Why?
|
| Sports | 1 | 2016 | 705 | 0.020 |
Why?
|
| Time | 1 | 2012 | 545 | 0.020 |
Why?
|
| Oximetry | 1 | 2013 | 460 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 654 | 0.020 |
Why?
|
| Angina Pectoris | 2 | 2004 | 959 | 0.020 |
Why?
|
| Causality | 1 | 2016 | 1243 | 0.020 |
Why?
|
| Social Change | 1 | 2010 | 153 | 0.020 |
Why?
|
| Indians, North American | 1 | 2013 | 352 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
| Glycosylation | 1 | 2013 | 1098 | 0.020 |
Why?
|
| Career Choice | 1 | 2016 | 756 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 2082 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2024 | 4463 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1999 | 4167 | 0.020 |
Why?
|
| Environment | 1 | 2015 | 1122 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11900 | 0.020 |
Why?
|
| Adipokines | 1 | 2011 | 310 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26211 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 11116 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2016 | 1878 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2024 | 3800 | 0.020 |
Why?
|
| Mexico | 1 | 2011 | 763 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1780 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 467 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2717 | 0.020 |
Why?
|
| ROC Curve | 1 | 2016 | 3572 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 2252 | 0.020 |
Why?
|
| Stilbenes | 1 | 2008 | 155 | 0.020 |
Why?
|
| Learning | 1 | 2017 | 1740 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2018 | 2568 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2017 | 1196 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2016 | 2494 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2009 | 296 | 0.020 |
Why?
|
| Parents | 1 | 2001 | 3564 | 0.020 |
Why?
|
| Peptides | 1 | 2019 | 4342 | 0.020 |
Why?
|
| Heart Atria | 1 | 2013 | 1346 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2010 | 773 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2016 | 42251 | 0.020 |
Why?
|
| Lead Poisoning | 1 | 2009 | 322 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 518 | 0.020 |
Why?
|
| Education | 1 | 2009 | 536 | 0.020 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 3082 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3420 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4244 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6815 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1738 | 0.020 |
Why?
|
| Lung | 1 | 2024 | 9994 | 0.020 |
Why?
|
| Emotions | 1 | 2016 | 2738 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2015 | 1514 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2105 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1202 | 0.010 |
Why?
|
| Sepsis | 1 | 2016 | 2587 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8470 | 0.010 |
Why?
|
| Antioxidants | 1 | 2008 | 1670 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7439 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2133 | 0.010 |
Why?
|
| Judgment | 1 | 2001 | 273 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7999 | 0.010 |
Why?
|
| Nursing Staff, Hospital | 1 | 2002 | 348 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22154 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2002 | 601 | 0.010 |
Why?
|
| Random Allocation | 1 | 2000 | 2389 | 0.010 |
Why?
|
| Disease | 1 | 2000 | 672 | 0.010 |
Why?
|
| Health Services Research | 1 | 2002 | 1811 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 36202 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2000 | 1525 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1998 | 1436 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2011 | 6839 | 0.010 |
Why?
|